<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64E99764-A3A6-4794-B81C-B0F1CC0A01EB"><gtr:id>64E99764-A3A6-4794-B81C-B0F1CC0A01EB</gtr:id><gtr:name>Creative Antibiotics</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Cellular and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64E99764-A3A6-4794-B81C-B0F1CC0A01EB"><gtr:id>64E99764-A3A6-4794-B81C-B0F1CC0A01EB</gtr:id><gtr:name>Creative Antibiotics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/52818C77-4685-4862-8524-ECA0EA07CC3D"><gtr:id>52818C77-4685-4862-8524-ECA0EA07CC3D</gtr:id><gtr:firstName>Ariel</gtr:firstName><gtr:otherNames>Judith</gtr:otherNames><gtr:surname>Blocker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401595"><gtr:id>696965F6-FC94-4A19-9243-24DACC49EFAC</gtr:id><gtr:title>Mechanism of secretion activation in the Shigella TTSS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401595</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Gram-negative bacteria commonly interact with eukaryotic host cells by using type III secretion systems (TTSSs or secretons). TTSSs serve to inject bacterial proteins directly into the host cell membrane and cytoplasm during infection. Secretons are activated for secretion only upon physical contact with host cells. How this host-pathogen signaling event occurs is not understood. Secretons are composed of cytoplasmic, transmembrane and extracellular domains. The extracellular domain is a hollow needle protruding 45 nm above the bacterial surface. The monomeric unit of the Shigella flexneri needle, MxiH, forms a helical assembly with parameters similar to those defining the architecture of the extracellular, axial components of bacterial flagella (Cordes et al., 2003). The segments of helically arranged single protein types that make up the different parts of the axial flagellum display remarkable kinds of different structural plasticity, for instance supercoiling and strong flexibility/curvature (Samatey et al., 2001 and 2004). The architectural homology between the TTSS needle and bacterial flagella along with other genetic, morphological and functional homologies, led us to propose (Blocker et al., 2003) that signaling of host cell-contact through TTSSs might occur via structural changes in the needle analogous to some controlling the structural plasticity of the flagellar filament (Samatey et al., 2001). To test our hypothesis, we propose to: 1) define the molecular architecture of the external needle that underlies activation of the Shigella TTSS for secretion by determining the helical structure of needles derived from MxiH mutants that lock the TTSS into different secretion states and by similar studies of physiologically activated TTSS, 2) to understand how the external needle communicates the activation signal to the basal body by using biochemical, genetic and EM techniques to study how the other components of the needle (including the probable MxiI periplasmic rod and a putative distal needle cap) interact with the basal body of the apparatus .</gtr:technicalSummary><gtr:fund><gtr:end>2009-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>386306</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Creative Antibiotics</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Identification of molecular target of small molecule T3SS inhibitors</gtr:description><gtr:id>BDAB050A-E7A0-42EB-824D-3980AF3A2DB7</gtr:id><gtr:impact>We believe we have identified the targets of the these drugs using a genetic screen and whole genome sequencing. This work is now published in PLoS One.</gtr:impact><gtr:outcomeId>DF4D6241E19-1</gtr:outcomeId><gtr:partnerContribution>Company gave inhibitory compounds to be tested.</gtr:partnerContribution><gtr:piContribution>We studied the effects of the compounds on Shigella flexneri and Salmonella typhimurium T3SS-related systems and have published one paper on the Shigella work already (PMID: 18996990), whilst the Salmonella work (PMID:23300965). Thus, this work in an indirect consequence of having MRC funding to support my lab in general. It paid for some of the consumables used by an EEC funded postdoc and a technician to do the work and it also supported part of the salary of the part-time technician.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Named collaborator on Wellcome Trust Programme Grant (WT083599) awarded to Prof. Susan Lea</gtr:description><gtr:id>F156D875-B946-4822-8CEF-F06D39D113DE</gtr:id><gtr:impact>Several publications have resulted from this work: for example Cordes et al., 2003 and 2005, PMID: 16888041 and PMID:19396171. In addition, both the Lea and the Blocker groups have independently won further funding for this work and were named collaborators on each other's grants.</gtr:impact><gtr:outcomeId>38E98B2C69D-1</gtr:outcomeId><gtr:partnerContribution>Provision of and/or handling of atomic resolution structures of components of the T3SS we study, which we can then collaboratively dock to the high-resolution EM structures we generate.</gtr:partnerContribution><gtr:piContribution>We provided functional biochemistry and EM/MS data regarding the T3SS of Shigella flexneri.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits in Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9E5B67F5-0E84-4E94-9FCA-8A111E25DF09</gtr:id><gtr:impact>Interactive presentations about &amp;quot;Infectious Diseases in the 21st century&amp;quot; to children from late primary to late secondary school age, right up to six formers at the Oxford Museum of Natural History.

We got invited back in following years.</gtr:impact><gtr:outcomeId>779ECEF5AC7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant G0701243</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2D6F62C5-FF20-481A-BA78-E1ADBAC3F8B2</gtr:id><gtr:outcomeId>27AE88A5F910</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>107471</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant WT082398 High resolution electron microscopy studies of the Shigella T3SS needle distal tip complex</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT082398</gtr:fundingRef><gtr:id>E724B698-8224-41CB-8F93-584976518E47</gtr:id><gtr:outcomeId>79EB502875F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>473686</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project grant WT088231 A high-resolution mass spectrometry and electron microscopy approach to understanding the function of the Shigella T3SS</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT088231</gtr:fundingRef><gtr:id>B87111EE-0FCF-4F37-9AAB-19E50CD9481E</gtr:id><gtr:outcomeId>31E8203216C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Short-Term fellowship</gtr:description><gtr:end>2007-07-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>22824E1C-5945-4847-961C-43E0A28DF4D2</gtr:id><gtr:outcomeId>BB1B4D63E890</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Funding to send Dr. Frank Booy to use Prof. Keiichi Namba's electron microscopes at the Graduate School for Frontier Biosciences at the University of Osaka, Japan, in 2006</gtr:description><gtr:end>2006-06-02</gtr:end><gtr:fundingOrg>The Nippon Foundation</gtr:fundingOrg><gtr:id>F26F01A5-145D-4935-BB08-4EB528CC31DF</gtr:id><gtr:outcomeId>DE81CF860120</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant MR/J002097/1</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J002097/1</gtr:fundingRef><gtr:id>AF57AFEE-EC24-4738-B9F4-A2649338A2F4</gtr:id><gtr:outcomeId>SabS9b6koET</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Purified needles and needle proteins were crucial to our following publications PMIDs: 16243352, 16511329, 17367391.</gtr:description><gtr:id>9BFD7E24-93A2-4B2C-B622-B9BEEF4F917E</gtr:id><gtr:impact>Others have used our recombinant needle protein purification strategy to investigate the structure of the these proteins from other species, enriching our overall understanding of these proteins. We have recently used our needle purification protocol to initiate higher resolution studies of this portion of the T3SS apparatus by cryoEM with Prof. Keiichi Namba.</gtr:impact><gtr:outcomeId>66F4E95EE44</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Methods of further purification of T3SS needle and its subunit component</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/16243352</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This method was crucial to our following papers: 17660405 and 1939617.</gtr:description><gtr:id>B5A27B45-E61E-4926-9528-9350FB35B191</gtr:id><gtr:impact>We are now using this method to purify NCs for high resolution mass spectrometry and cryoEM, in collaboration with Dr. Frank Sobott and Prof. Keiichi Namba, as part of project grant WT088231. Prof. Susan Lea's lab in using this protocol to purify &amp;quot;needleless&amp;quot; NC bases for crystallography trials.</gtr:impact><gtr:outcomeId>8AD5DD541CE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Method to affinity purify T3SS needle complexes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The EM map and a 22-mer pseudoatomic needle model were deposited in the Electron Microscopy Data Bank and the Protein Data Bank under accession numbers EMD-5352 and 3J0R, respectively.</gtr:description><gtr:id>0D3BDA8D-027C-45DD-A192-7C1136DED723</gtr:id><gtr:impact>Comparison with other research data such as the following paper:
Atomic model of the type III secretion system needle.
Loquet A, Sgourakis NG, Gupta R, Giller K, Riedel D, Goosmann C, Griesinger C, Kolbe M, Baker D, Becker S, Lange A.
Nature. 2012 May 20;486(7402):276-9. doi: 10.1038/nature11079. Erratum in: Nature. 2012 Aug 30;488(7413):684. 

Please see also associated corrigendum:
Loquet A, Sgourakis NG, Gupta R, Giller K, Riedel D, Goosmann C, Griesinger C, Kolbe M, Baker D, Becker S, Lange A.
Nature. 2012 Aug 8. doi: 10.1038/nature11350.

and subsequent publication:
High-resolution structure of the Shigella type-III secretion needle by solid-state NMR and cryo-electron microscopy.
Demers JP, Habenstein B, Loquet A, Kumar Vasa S, Giller K, Becker S, Baker D, Lange A, Sgourakis NG.
Nat Commun. 2014 Sep 29;5:4976. doi: 10.1038/ncomms5976.</gtr:impact><gtr:outcomeId>C3sHGwuoHdQ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>7A resolution electron density map of the Shigella T3SS needle</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ebi.ac.uk/pdbe/entry/EMD-5352</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>See http://emsearch.rutgers.edu/atlas/1617_summary.html The map has been deposited within the relevant database for this sort of data, EMDEP held at the EBI in Hinxton. It is a 25A-resolution electron density map of the major part of the bacterial virulence device we work on.</gtr:description><gtr:id>85DDCED2-9163-4FE9-B165-4FE94F4BBAE3</gtr:id><gtr:impact>None as yet, but has helped others (competitors and collaborators) and ourselves dock available crystal structures of subunits of the complex and/or improve the resolution of any future cryoEM 3D reconstructions of T3SS &amp;quot;needle complexes&amp;quot;.</gtr:impact><gtr:outcomeId>2E925CEB23F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>C12 symmetrised 3D reconstruction of the Shigella 'needle complex'</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://emsearch.rutgers.edu/atlas/1617_summary.html</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Creative Antibiotics</gtr:companyName><gtr:description>Creative Antibiotics is developing virulence blockers which can be alternative or complementary to current antibiotics.
Currently, Creative Antibiotics has three projects: agents against infections in severe burns, agents against diarrhoea and agents against chlamydia infections.
http://www.creativeantibiotics.com/default.asp?LID=1</gtr:description><gtr:id>8AD16624-73FF-4E3D-9237-4EDB9A9A51B3</gtr:id><gtr:impact>Tried to use our understanding of T3SS distal needle tip complex to help company design better PcrV inhibitors.
Unfortunately, they went out of business in June 2013.</gtr:impact><gtr:outcomeId>HuuyYM7hoTn</gtr:outcomeId><gtr:url>http://www.creativeantibiotics.com/default.asp?LID=1</gtr:url></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>5631DEBD-2401-4A87-A645-2134A328C927</gtr:id><gtr:title>Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>092C37FA9BF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C92E9BF4-E9DE-40EF-ABDD-7FFDB7A13A98</gtr:id><gtr:title>Expression, limited proteolysis and preliminary crystallographic analysis of IpaD, a component of the Shigella flexneri type III secretion system.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>092D7CF3275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE225F94-196F-4517-A533-F12CB376F3AB</gtr:id><gtr:title>Structural and functional studies on the N-terminal domain of the Shigella type III secretion protein MxiG.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33eed3282e1315f1f217059dd1a1bdc8"><gtr:id>33eed3282e1315f1f217059dd1a1bdc8</gtr:id><gtr:otherNames>McDowell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_16040_20_21733840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CD7FBD4-FF63-4F63-BD2F-D3C4A528C730</gtr:id><gtr:title>The needle component of the type III secreton of Shigella regulates the activity of the secretion apparatus.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f461bec06a9c9c051d28866360a9959e"><gtr:id>f461bec06a9c9c051d28866360a9959e</gtr:id><gtr:otherNames>Kenjale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0920DACC4B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D7DD06D-646F-406F-B472-D5273A6F040D</gtr:id><gtr:title>The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c63d62e17b9d548a7102927d64372af"><gtr:id>8c63d62e17b9d548a7102927d64372af</gtr:id><gtr:otherNames>Martinez-Argudo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>9974C7B2_09974C7B2_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8CDF317-9617-4DC3-83C0-4EADFD54B9C3</gtr:id><gtr:title>Identification of minor inner-membrane components of the Shigella type III secretion system 'needle complex'.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c0b9516018100242f5ef110b8b1431c"><gtr:id>6c0b9516018100242f5ef110b8b1431c</gtr:id><gtr:otherNames>Zenk SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>939ED81272D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6712D5A-5B12-4836-AB08-9786F14E216F</gtr:id><gtr:title>Characterization of soluble complexes of the Shigella flexneri type III secretion system ATPase.</gtr:title><gtr:parentPublicationTitle>FEMS microbiology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0378-1097</gtr:issn><gtr:outcomeId>96D7B4E7D39</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B40AB697-9487-4AC8-8A83-B8F17635D582</gtr:id><gtr:title>What's the point of the type III secretion system needle?</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b993ec058b6368ef13c6f0c7f9cfb5a"><gtr:id>2b993ec058b6368ef13c6f0c7f9cfb5a</gtr:id><gtr:otherNames>Blocker AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>3F50B54C31C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56811B3E-ED8E-475C-B385-DED056EEF73E</gtr:id><gtr:title>Structure of a type III secretion needle at 7-&amp;Aring; resolution provides insights into its assembly and signaling mechanisms.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de24341f277fee3eb60e20b7c8bc34e8"><gtr:id>de24341f277fee3eb60e20b7c8bc34e8</gtr:id><gtr:otherNames>Fujii T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_16040_20_22388746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29D0DD22-98E5-49D1-9142-0B20486E1A4A</gtr:id><gtr:title>The type III secretion system needle tip complex mediates host cell sensing and translocon insertion.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445de988dce249602b05543cdc990cfc"><gtr:id>445de988dce249602b05543cdc990cfc</gtr:id><gtr:otherNames>Veenendaal AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>C61D344E2FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D39D0A1-8112-486B-ABE5-694019E6107E</gtr:id><gtr:title>The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5819d8771dad9f02d80ca1d61fdacca1"><gtr:id>5819d8771dad9f02d80ca1d61fdacca1</gtr:id><gtr:otherNames>Roehrich AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>PYStA1vUJoY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B5AF5FE-D291-4090-A870-737B310826A3</gtr:id><gtr:title>Expression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b88b929221beddf8948daa6e2e50c8c1"><gtr:id>b88b929221beddf8948daa6e2e50c8c1</gtr:id><gtr:otherNames>Deane JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>FA6786507EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE147B57-2867-4C85-A3B7-BFA5CE3AADD7</gtr:id><gtr:title>Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9baa3eefdd943bb189825de98630ade"><gtr:id>c9baa3eefdd943bb189825de98630ade</gtr:id><gtr:otherNames>Hodgkinson JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>1223A6755CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7B9EC4-4D09-4AE2-B495-0DB323F827E3</gtr:id><gtr:title>Helical packing of needles from functionally altered Shigella type III secretion systems.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7a5cfcdc3149312567f28a4afd53d6"><gtr:id>5e7a5cfcdc3149312567f28a4afd53d6</gtr:id><gtr:otherNames>Cordes FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>2F91AA174F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF9D69C4-5246-41CF-832A-95F44D14930D</gtr:id><gtr:title>Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445de988dce249602b05543cdc990cfc"><gtr:id>445de988dce249602b05543cdc990cfc</gtr:id><gtr:otherNames>Veenendaal AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>7C9300A7C6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A90DE4B-7928-4379-A0BC-2DF78DBE5F7C</gtr:id><gtr:title>Molecular model of a type III secretion system needle: Implications for host-cell sensing.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b88b929221beddf8948daa6e2e50c8c1"><gtr:id>b88b929221beddf8948daa6e2e50c8c1</gtr:id><gtr:otherNames>Deane JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>2C40230B562</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401595</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>